Regulation: Standards, policy, compliance, and enforcement for good manufacturing practices and good laboratory practices - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Regulation
Industry guidances and drafts by organizations like FDA, ICH, EMEA, USP & IPEC. Harmonization. Government policy. Validation, inspection, CGMP, imports & safety. Quality by Design (QbD), process analytical technology.

Regulatory Roundup: FDA Published The International Conference On Harmonization S9 Guideline; ISPE Released A New Good Practice Guide On Manufacturing Execution Systems.

March 11, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

FDA Published The International Conference on Harmonization S9 Guideline; ISPE Released A New Good Practice Guide On Manufacturing Execution Systems.

WHO Releases New Malaria Treatment and Drug-Procurement Guidelines

March 11, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

The World Health Organization released new guidelines this week for the treatment of malaria and the first-ever guidelines on procuring safe and efficacious antimalarial drugs.

Week Of March 8, 2010: Company And People Notes: Exelixis And XenoPort Announce Job Cuts; GSK Dedicates India Facility; And More.

March 11, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Exelixis And XenoPort Announce Job Cuts; GSK Dedicates India Facility; And More.

PhRMA Seeks Policy Changes to Proposed Russian Pharmaceutical Law

March 11, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

The Pharmaceutical Research and Manufacturers of America, along with eight other pharmaceutical, business, and trade organizations, are calling on Russian authorities to consider policy changes concerning clinical-trial regulation and intellectual property.

FDA Issues Guidance for Manufacturing Cell-Based Viral Vaccines

March 11, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

The US Food and Drug Administration recently published guidance for the characterization and qualification of cell substrates, viral seeds, and other biological materials used to manufacture viral vaccines for human use.

Managing Your Risk Has Its Rewards: No Nasty Surprises, for Instance

March 9, 2010

In this paper, we will examine a real-world example of how using a risk assessment model in a quality management system can identify critical adverse events, mitigate the risk, and prevent re-occurrence of these events.

FDA and EMA Allow Single Annual Report for Orphan Drugs

March 4, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

The US Food and Drug Administration and the European Medicines Agency are implementing a streamlined process to help regulators better identify and share information regarding orphan-drug and biologic products.

Week Of March 1, 2010: Company And People Notes: Astellas Pharma Makes Bid for OSI Pharmaceuticals; Ringo Retiring From Pfizer; And More.

March 4, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology

Astellas Pharma Makes Bid for OSI Pharmaceuticals; Ringo Retiring From Pfizer; And More.

FDA and NIH Collaborate to Speed the Introduction of New Medicines

March 4, 2010

ePT--the Electronic Newsletter of Pharmaceutical Technology

Last week, the US Food and Drug Administration and the National Institutes of Health unveiled plans to establish a Joint Leadership Council to address important public-health issues.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
When sourcing raw materials and non-GMP intermediates or other chemicals, where are the majority of your suppliers located?
In the United States
In Western Europe
In Central and Eastern Europe
In Japan
In India
In China
In the United States
22%
In Western Europe
18%
In Central and Eastern Europe
3%
In Japan
2%
In India
28%
In China
28%
View Results
Jim MillerOutsourcing OutlookJim Miller Time for a Model Upgrade
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Navigating the Global Pharmaceutical Supply Chain
Faiz kermaniSpotlightFaiz Kermani Reinvigorating European R&D innovation
Faiz kermaniStatistical Solutions Lynn Torbeck%RSD: Friend or Foe?
FindPharma Custom Search
Click here